Public engagement is often found at the heart of universities’ mission statements and is key to their institutional identities, but it is rarely central in their promotion and tenure processes. Indeed ...

The US Food and Drug Administration (FDA) has created a new pathway to bring personalised therapies to market that can bypass certain requirements, using the success of Baby KJ’s treatment as a ...

In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory pathway that could trigger a seismic shift in how bespoke gene editing therapies ...

Schools across the country are offering courses and retreats for people 50+ who want to reinvent themselves and embrace lifelong learning and discovery.

Urnov is a professor of molecular therapeutics at the University of California, Berkeley, and a director at its Innovative Genomics Institute. In May, news broke of a biomedical first: the on-demand ...

“Companies should really sit down and say, could I meet these points?” Hogan Lovells partner Lynn Mehler said. “How do I follow the larger concept at play here, which is FDA willingness to be ...